Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

High-Content Imaging | Molecular DevicesHigh-Content Imaging | Molecular Devices
VS
Syneos HealthSyneos Health
High-Content Imaging | Molecular Devices

High-Content Imaging | Molecular Devices

N/A

Last Update: 25/03/2026

View Profile

We empower researchers with cutting-edge AI-driven high-content screening solutions, delivering deeper insights into complex biological models. Our innovative ImageXpress® HCS.ai High-Content Screening System and IN Carta® Image Analysis Software streamline workflows fo...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
Syneos Health

Syneos Health

1030 Sync Street, Morrisville, 27560, US

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.syneoshealth.com
794/1000Fair

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a ta...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:23,166
Subsidiaries:17
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
High-Content Imaging | Molecular Devices

High-Content Imaging | Molecular Devices

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Syneos Health

Syneos Health

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for High-Content Imaging | Molecular Devices in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Syneos Health in 2026.

Incidents

Incident History - High-Content Imaging | Molecular Devices (X = Date, Y = Severity)

High-Content Imaging | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Syneos Health (X = Date, Y = Severity)

Syneos Health cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
High-Content Imaging | Molecular Devices

High-Content Imaging | Molecular Devices

Incidents
No explicit notable incidents reported.
Syneos Health

Syneos Health

Incidents
No explicit notable incidents reported.

FAQ

Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has the best AI Cybersecurity Score ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has experienced more cyber incidents in the past ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has experienced more cyber incidents this year ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has experienced at least one ransomware attack ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has experienced at least one data breach ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has experienced at least one targeted cyberattack ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has experienced at least one vulnerability ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one holds the most compliance certifications ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one holds the fewest compliance certifications ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has the most subsidiaries ?
Between High-Content Imaging | Molecular Devices company and Syneos Health company, which one has the largest number of employees ?
Between High-Content Imaging | Molecular Devices and Syneos Health, which company holds both SOC 2 Type 1 certifications ?
Between High-Content Imaging | Molecular Devices and Syneos Health, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - High-Content Imaging | Molecular Devices or Syneos Health ?
Which company is PCI DSS compliant - High-Content Imaging | Molecular Devices or Syneos Health ?
Between High-Content Imaging | Molecular Devices and Syneos Health, which company complies with HIPAA regulations for healthcare data ?
Between High-Content Imaging | Molecular Devices and Syneos Health, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-50044
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-44955
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-42933
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 10)
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 10.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.9
CVE-2026-40430
SUMMARY

Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-28698
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 8.6)
CVSS3
Base Score: 8.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
CVSS4
Base Score: 9.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
3.9